BREAKING

Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago

ROIV

Roivant Sciences

$ROIV NASDAQ Feb 6, 2026

Pending

EPS Actual —

Revenue —

EPS Surprise —

Status Pending

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

ROIV Coverage

Event Roivant Sciences (ROIV) Sec Form 10Q Feb 7, 2026 News Roivant Reports Q3 Results, Cites Phase 2 Breakthrough and Catalyst-Rich 2026 Feb 6, 2026 News Roivant Sciences Reports Fiscal Third Quarter 2025 Results Amid Robust Pipeline Advancement Feb 6, 2026 Event Roivant Sciences (ROIV) Q2 2026 Earnings Call Feb 6, 2026 Transcript Roivant Sciences (ROIV) Q3 2025 Earnings Call Transcript Jan 22, 2026 Transcript Roivant Sciences (ROIV) Q4 2025 Earnings Call Transcript Jan 22, 2026